WallStreetZenWallStreetZen

NASDAQ: GLRE
Greenlight Capital Re Ltd Stock

$12.05-0.10 (-0.82%)
Updated Apr 26, 2024
GLRE Price
$12.05
Fair Value Price
$13.94
Market Cap
$426.11M
52 Week Low
$9.48
52 Week High
$12.89
P/E
4.73x
P/B
0.71x
P/S
0.58x
PEG
0.02x
Dividend Yield
N/A
Revenue
$667.08M
Earnings
$86.83M
Gross Margin
46%
Operating Margin
13.83%
Profit Margin
13%
Debt to Equity
1.91
Operating Cash Flow
$8M
Beta
0.68
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

GLRE Overview

Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurance company worldwide. The company offers various property reinsurance products and services, including automobile physical damage, personal lines, and commercial lines. It also provides casualty reinsurance products and services comprising general liability, motor liability, professional liability, and worker's compensation; and accident and health, transactional liability, mortgage insurance, surety, trade credit, marine, energy, aviation, crop, cyber, political, and terrorism products. The company markets its products through reinsurance brokers. Greenlight Capital Re, Ltd. was incorporated in 2004 and is headquartered in Grand Cayman, the Cayman Islands.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GLRE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GLRE ($12.05) is undervalued by 13.55% relative to our estimate of its Fair Value price of $13.94 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GLRE ($12.05) is not significantly undervalued (13.55%) relative to our estimate of its Fair Value price of $13.94 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
GLRE ($12.05) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GLRE due diligence checks available for Premium users.

Be the first to know about important GLRE news, forecast changes, insider trades & much more!

GLRE News

Valuation

GLRE fair value

Fair Value of GLRE stock based on Discounted Cash Flow (DCF)
Price
$12.05
Fair Value
$13.94
Undervalued by
13.55%
GLRE ($12.05) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GLRE ($12.05) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GLRE ($12.05) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GLRE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
4.73x
Industry
7.24x
Market
41.14x
GLRE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
GLRE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

GLRE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.71x
Industry
1.16x
GLRE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GLRE price to earnings growth (PEG)

For valuing profitable companies with growth potential
GLRE is good value based... subscribe to Premium to read more.
PEG Value Valuation

GLRE's financial health

Profit margin

Revenue
$155.5M
Net Income
$17.6M
Profit Margin
11.3%
GLRE's Earnings (EBIT) of $92.27M... subscribe to Premium to read more.
Interest Coverage Financials
GLRE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.7B
Liabilities
$1.1B
Debt to equity
1.91
GLRE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GLRE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$22.1M
Investing
-$30.6M
Financing
$0.0
GLRE's operating cash flow ($7.51M)... subscribe to Premium to read more.
Debt Coverage Financials

GLRE vs Reinsurance Insurance Stocks

TickerMarket Cap1d %P/EP/B
GLRE$426.11M-0.82%4.73x0.71x
MHLD$208.98M-0.24%-5.47x0.84x
OXBR$6.16M-0.94%-0.62x1.16x
HG$1.52B-2.42%5.55x0.74x
SPNT$2.05B+1.60%6.26x0.82x

Greenlight Capital Re Stock FAQ

What is Greenlight Capital Re's quote symbol?

(NASDAQ: GLRE) Greenlight Capital Re trades on the NASDAQ under the ticker symbol GLRE. Greenlight Capital Re stock quotes can also be displayed as NASDAQ: GLRE.

If you're new to stock investing, here's how to buy Greenlight Capital Re stock.

What is the 52 week high and low for Greenlight Capital Re (NASDAQ: GLRE)?

(NASDAQ: GLRE) Greenlight Capital Re's 52-week high was $12.89, and its 52-week low was $9.48. It is currently -6.52% from its 52-week high and 27.11% from its 52-week low.

How much is Greenlight Capital Re stock worth today?

(NASDAQ: GLRE) Greenlight Capital Re currently has 35,361,725 outstanding shares. With Greenlight Capital Re stock trading at $12.05 per share, the total value of Greenlight Capital Re stock (market capitalization) is $426.11M.

Greenlight Capital Re stock was originally listed at a price of $24.03 in May 24, 2007. If you had invested in Greenlight Capital Re stock at $24.03, your return over the last 16 years would have been -49.85%, for an annualized return of -4.22% (not including any dividends or dividend reinvestments).

How much is Greenlight Capital Re's stock price per share?

(NASDAQ: GLRE) Greenlight Capital Re stock price per share is $12.05 today (as of Apr 26, 2024).

What is Greenlight Capital Re's Market Cap?

(NASDAQ: GLRE) Greenlight Capital Re's market cap is $426.11M, as of Apr 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Greenlight Capital Re's market cap is calculated by multiplying GLRE's current stock price of $12.05 by GLRE's total outstanding shares of 35,361,725.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.